
    
      This study is a two-part, partially blinded, placebo controlled, combined single ascending
      dose (SAD) with food-effect and multiple ascending dose (MAD) study conducted in one study
      center in the United States.

      Safety will be assessed throughout the study for all subjects. Safety assessments will
      include physical examinations, vital signs, serial ECGs, cardiac monitoring, adverse events
      (AEs), and clinical laboratory tests (including hematology, serum chemistry, coagulation, and
      urinalysis).
    
  